|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for prophylactic immunotherapy
ICD-10 (CM) Code and Descriptor
|
Z29.12 |
Encounter for prophylactic antivenin
This code is considered unacceptable as a principal diagnosis.
|
Z2912 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 11 |
ICD10
Position 13 |
ICD10
Position 15 |
| 32.56%
|
6.98%
|
9.30%
|
2.33%
|
2.33%
|
4.65%
|
2.33%
|
2.33%
|
2.33%
|
2.33%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z29.12*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
U0003
|
COV-19 AMP PRB HGH THRUPUT |
41
|
41
|
|
U0005
|
INFEC AGEN DETEC AMPLI PROBE |
41
|
41
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
17
|
17
|
|
85027
|
COMPLETE CBC AUTOMATED |
14
|
14
|
|
80053
|
COMPREHEN METABOLIC PANEL |
9
|
9
|
|
80048
|
METABOLIC PANEL TOTAL CA |
4
|
4
|
|
83540
|
ASSAY OF IRON |
4
|
4
|
|
82785
|
ASSAY OF IGE |
3
|
3
|
|
G2025
|
DIS SITE TELE SVCS RHC/FQHC |
3
|
3
|
|
87088
|
URINE BACTERIA CULTURE |
2
|
2
|
|
83550
|
IRON BINDING TEST |
2
|
2
|
|
80061
|
LIPID PANEL |
2
|
2
|
|
81003
|
URINALYSIS AUTO W/O SCOPE |
1
|
1
|
|
80306
|
DRUG TEST PRSMV INSTRMNT |
1
|
1
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
1
|
1
|
|
87077
|
CULTURE AEROBIC IDENTIFY |
1
|
1
|
|
87186
|
MICROBE SUSCEPTIBLE MIC |
1
|
1
|
|
83735
|
ASSAY OF MAGNESIUM |
1
|
1
|
|
82728
|
ASSAY OF FERRITIN |
1
|
1
|
|
85046
|
RETICYTE/HGB CONCENTRATE |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z29.12 related to the following DRG Codes:
951
|
